Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

332.59 -3.08 (-0.92%)
Official Closing Price Updated: 6:30 PM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
News headline image
1 Oversold Stock Primed to Rebound and 2 We Question
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investo... 
Via StockStory
News headline image
Stocks making big moves yesterday: El Pollo Loco, Stryker, Dollar Tree, Coinbase, and Distribution Solutions
Check out the companies making headlines yesterday: El Pollo Loco (NASDAQ:LOCO): Fast food chain El Pollo Loco (NASDAQ:LOCO) rose by 5.4% on Monday after the... 
Via StockStory
News headline image
Stryker (SYK) Stock Is Up, What You Need To Know
What Happened? Shares of medical technology company Stryker (NYSE:SYK) jumped 3.2% in the afternoon session after investors appeared to buy the dip after the... 
Via StockStory
Topics Economy Government World Trade
Stryker Corp (NYSE:SYK): A Quality Dividend Growth Stock for Durable Income ↗
Via Chartmill
Stryker Corp (NYSE:SYK) Beats Q4 EPS Estimates, Provides 2026 Guidance ↗
Via Chartmill
News headline image
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global... 
Via Finterra
Topics Earnings Economy Hacking
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships. 
Via The Motley Fool
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Stryker Shipping Stock Slips As Cyberattack-Spurred Outage Drags On ↗
Bloomberg reported on Thursday that the company’s ordering and shipping systems are still offline following a cyberattack, claimed by pro-Iranian digital activist group Handala, on Wednesday. 
Via Stocktwits
Topics Malware
Oracle Steals the Show as Oil Tensions Rattle Wall Street ↗
Via Chartmill
News headline image
SYK Stock Slips On Report Of Global Outage Spurred By Suspected Iran-Linked Cyberattack ↗
The Wall Street Journal reported that the outage, which began after midnight on the East Coast, has had an impact across Stryker systems. 
Via Stocktwits
News headline image
Winners And Losers Of Q4: Stryker (NYSE:SYK) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices &... 
Via StockStory
News headline image
1 S&P 500 Stock with Solid Fundamentals and 2 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property Stocks
News headline image
1 Profitable Stock to Keep an Eye On and 2 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute
News headline image
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data
As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector... 
Via MarketMinute
Topics Artificial Intelligence ETFs Earnings
News headline image
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
Today’s Date: February 17, 2026 Introduction Medtronic plc (NYSE: MDT) has long been the sleeping giant of the medical technology sector. For years, the Dublin-domiciled powerhouse was viewed by Wall... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left... 
Via Finterra
Topics Product Recall World Trade
News headline image
Stryker declares an $0.88 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race
In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The... 
Via MarketMinute
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Stryker (SYK) Q4 2025 Earnings Call Transcript ↗
Stryker (SYK) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates
Medical technology company Stryker (NYSE:SYK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.4% year on year to $7.17 billion. Its non-GAAP profit of $4.47 per... 
Via StockStory
News headline image
Stryker reports 2025 operating results and 2026 outlook
From Stryker Corporation
Via GlobeNewswire
News headline image
Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation
MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.